Global Recombinant Antibody Market Growth (Status and Outlook) 2025-2031

Global Recombinant Antibody Market Growth (Status and Outlook) 2025-2031

The global Recombinant Antibody market size is predicted to grow from US$ 195 million in 2025 to US$ 211 million in 2031; it is expected to grow at a CAGR of 1.3% from 2025 to 2031.

Recombinant antibodies are antibodies produced through genetic engineering techniques, often using mammalian cells or other expression systems. They are used in research, diagnostics, and therapeutics.

The market for recombinant antibodies is growing due to their versatility in applications, including cancer therapy, autoimmune disease treatment, and targeted drug delivery. Advances in antibody engineering and production technologies are contributing to this trend.

LPI (LP Information)' newest research report, the “Recombinant Antibody Industry Forecast” looks at past sales and reviews total world Recombinant Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Antibody sales for 2025 through 2031. With Recombinant Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Antibody industry.

This Insight Report provides a comprehensive analysis of the global Recombinant Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Recombinant Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Antibody market by product type, application, key players and key regions and countries.

Segmentation by Type:
Chimeric Antibody
Humanized Antibody
Full Human Antibody
Single Chain Antibody
Bispecific Antibody

Segmentation by Application:
Hospital
Scientific Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abnova
Medix Biochemica
GE Healthcare
SinoBiological
Bioventix

Please note: The report will take approximately 2 business days to prepare and deliver.